CytomX Therapeutics (CTMX) Files $250M Mixed Shelf
Tweet
Share
E-mailGet Alerts CTMX Hot Sheet
Join SI Premium – FREE
CytomX Therapeutics (NASDAQ: CTMX) has filed $250,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Takeda names Julie Kim as president and CEO after shareholder vote
- Exelixis (EXEL) Reiterated at Market Outperform by Citizens on Q2 Cabo Script Growth
- Goldman Sachs Assumes Braze Inc (BRZE) at Buy
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
